Glycopyrrolate
NDC 69315-139, Glycopyrrolate, tablet, from Leading Pharma, LLC.
- Product NDC
- 69315-139
- Status
- Listed
- Labeler
- Leading Pharma, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090195
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69315-139 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLYCOPYRROLATE1 mg/1
Pharmacologic classes
Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69315-139-01 | 69315013901 | 100 TABLET in 1 BOTTLE (69315-139-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/498bce66-6072-4212-8413-ff9888c58f9cNADAC price for package 69315013901
GET /v1/drugs/nadac/69315013901
Use it
Look up 69315-139 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69315-139 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69315-139. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.